Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Events
Sections
Divisions
Programs
- Developmental Genotype-Tissue Expression (dGTEx)1
- Multi-Omics for Health and Disease (Multi-Omics)1
- Ethical, Legal and Social Implications (ELSI) Research Program2
- Genomics-Enabled Learning Health Systems (gLHS)2
- Genetic Architecture of Complex Traits1
- Genome Technology Program1
- Impact of Genomic Variation on Function (IGVF) Consortium3
- Molecular Phenotypes of Null Alleles in Cells (MorPhiC)1
- Clinical Genome (ClinGen) Resource1
- Genomic Innovator Awards1
- Polygenic RIsk MEthods in Diverse populations (PRIMED) Consortium1
- NHGRI Genomic Data Science Analysis, Visualization and Informatics Lab-space (AnVIL)2
- Genomics Research to Elucidate the Genetics of Rare Diseases (GREGOR) Consortium2
Policy Issues
The GINA is an important U.S. civil rights law that protects individuals from discrimination based on their genetic information.
… Congress in the 1990s at a time when genetic testing and genetics research was taking off at breakneck speed. GINA … diagnose a disease, or they might refuse to participate in genetics research. H.R. 2748 would prohibit insurance … protections against employment discrimination based on genetics. More on that later!  1996 Sen. Olympia Snowe …
Timeline
A timeline highlighting key moments in the development of eugenics, with a focus on the American eugenics movement.
… claims it is possible to perfect people and groups through genetics and the scientific laws of inheritance. Eugenicists … current and future discriminatory trends that misuse genetics and, through its association, genomics, this … current and future discriminatory trends that misuse genetics and, through its association, genomics, this …
About Genomics
An interactive timeline listing key moments from the history of the project.
FAQ
On October 10, 2024, NHGRI hosted a pre-application webinar for the Population Genomic Screening in Primary Care NOFOs: RFA-HG-24-021, RFA-HG-24-022, and RFA-HG-24-023. These FAQs contain questions answered during that webinar.
… award. CGs should not budget for DNA extraction.  What clinical variant types will be screened? Specifically, will … CNVs and structural variants be returned?  The type of clinical variants to be screened and returned will be decided … Network-agreed protocols should they be different.  Can Clinical Groups (CGs) offer at-home saliva collection kits? …
Event
On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to provide an overview of three notice of funding opportunities (RFA-HG-24-001, PAR-24-106 and PAR-24-107). Questions were answered during the webinar.
… teratogenic exposures have traditionally been the part of genetics services, the national MotherToBaby resource already … Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)  PA-23-232 : PHS 2023-2 Omnibus … Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)  PA-23-231 : PHS 2023-2 Omnibus …
FAQ
Questions and answers to help applicants responding to the ML/AI Tools to Advance Genomic Translational Research (MAGen) notice of funding opportunities (NOFOs): RFA-HG-24-004 and RFA-HG-24-005.
… effect predictors within your model.  How integral is clinical expertise to the activities of the NOFO?  Clinical expertise in the proposed disease should be … will be informed by such expertise and have utility in clinical settings in the future.  What are potential …